Key Insights

Highlights

Success Rate

67% trial completion

Treatment Research

5 treatments under study, led by Concha Bullosa Resection

Research Leaders

8 sponsors active, led by Helsinki University Central Hospital

Related Conditions

Often studied with 14 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

25.0%

1 terminated out of 4 trials

Success Rate

66.7%

-19.9% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

67% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Not Yet Recruiting1
Terminated1

Trial Success Rate

66.7%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT04447521Completed

Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium

NCT07711756Not Yet Recruiting

Comparative Study of Adherence to Antibiotic Therapy Among Pediatric Patients: Hospital Emergency Department vs. Primary Care Center

NCT06687629Not ApplicableCompleted

Best Practice in the Management of Concha Bullosa in FESS Operation

NCT03584737TerminatedPrimary

Point-of-Care Immunoassay for Detection of Bacterial Sinusitis

Showing all 4 trials

Research Network

Common Treatments

  • Concha Bullosa Resection1
  • Pcr Assay1
  • Bacterial Culture1
  • Rapid In Vitro Diagnostic Test1
  • Concha Bullosa Crushing1

Active Sponsors

  • Helsinki University Central Hospital1
  • Beaufort1
  • ENTvantage Dx1
  • Merck Sharp & Dohme LLC1
  • University Hospital, Montpellier1

Top Investigators

Related Conditions

  • Pneumonia Bacterial1
  • Cystitis Acute1
  • Concha Bullosa1
  • Impetigo1
  • Otitis Media Acute1

Activity Timeline